[Treatment and follow up protocol in differentiated thyroid carcinomas of follicular origin].
Differentiated thyroid carcinoma of follicular origin (DTCFO), although not very frequent, has registered a raising incidence in the last decades. In the majority of the cases, DTCFO is a curable disease when treated and monitored by experienced, multidisciplinary teams. These factors contribute to an increasing number of DTCFO survivors requiring life-long monitoring, due to the possibility of occurrence of recurrences many years after the initial treatment. Several aspects of the treatment and management of these patients are still controversial. The present protocol represents the consensus of the members of the Grupo de Estudo da Tiróide of the Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo. It aims to define guidelines, in agreement with the current state of the art and contemplating the necessary adaptations to local constrains, that ensure decreased mortality and protection of patients' quality of life, avoiding unnecessarily aggressive or ineffective treatments, optimizing the use of the available resources.
Rodrigues
Fernando
F
Limbert
Edward
E
Marques
Ana Paula
AP
Santos
Ana Paula
AP
Lopes
Carlos
C
Rodrigues
Elizabete
E
Borges
Fátima
F
Carrilho
Francisco
F
Castro
João Jácome de
JJ
Neto
João
J
Salgado
Lucília
L
Oliveira
Maria João
MJ
D002985:Clinical Protocols; D005500:Follow-Up Studies; D006801:Humans; D013964:Thyroid Neoplasms / Q000628:therapy*